Is A Rise Imminent For Inovio Pharmaceuticals Stock After A Large 17% Fall In A Month

The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17% over the last month, while it is down 8% over the last week. This can be attributed to the spread of the new Covid-19...